References
- Tantawichien T Dengue fever and dengue hemorrhagic fever in adults. Southeast Asian J Trop Med Public Health. 2015; 46:79-98.26506734
- World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: WHO; 1997. p. 12-47.
- World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: WHO; 2009. p. 11-26.
- World Health Organization Regional Office for South-east Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded edition. New Delhi: WHO SEARO; 2011. p.29-37.
- van Gorp EC, Suharti C, Mairuhu AT, Dolmans WM, van Der Ven J, Demacker PN, et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis. 2002; 34:1150-3.1191500710.1086/339539
- Chuansumrit A, Puripokai C, Butthep P, Wongtiraporn W, Sasanakul W, Tangnararatchakit K, Chunhakan S, et al. Laboratory predictors of dengue shock syndrome during the febrile stage. Southeast Asian J Trop Med Public Health. 2010; 41:326-32.20578515
- Nernsai P. Sungkanuparph S. Predictors of dengue hemorrhagic fever in adult patients with dengue virus infection. J Infect Dis Antimicrob Agents. 2013; 30: 135-43.
- Biswas HH, Gordon A, Nuñez A, Perez MA, Balmaseda A, Harris E. Lower low-density lipoprotein cholesterol levels are associated with severe dengue outcome. PLoS Negl Trop Dis. 2015; 9: e0003904.2633491410.1371/journal.pntd.0003904
- Owen JS, Brown DJ, Harry DS, McIntyre N, Beaven GH, Isenberg H, et al. Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins. J Clin Invest. 1985; 76:2275-85.407797910.1172/JCI112237